Epidiolex and Drug Resistant Epilepsy in Children

Available (expanded access)

Conditions studied: Epilepsy

In brief

This open-label, multi-center study is open to patients 1 to 18 years of age at time of enrollment with medication resistant epilepsy.

Key facts

Study ID

NCT02397863

Run by

Augusta University

Starts

2014-12-01

Expected to finish

2020-01-01

Last updated by the study team

2015-04-24

Who can join

Age: 1 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient should have history of trying at least four antiepileptic drugs (AEDs), including one trial of a combination of two concomitant drugs, without successful seizure control. Vagal nerve stimulation, RNS deep brain stimulation, or the ketogenic diet can be considered equivalent to a drug trial.
• Patient must be taking two or more AEDs at a dose which has been stable for at least four weeks.
• A State of Georgia resident.

You may not qualify if…

• Patient is diagnosed as having Dravet Syndrome or Lennox-Gastaut Syndrome and eligible for a GW Pharmaceutical-Sponsored Clinical Trial.
• Patients who have been part of a clinical trial involving another investigational product in the previous six months.

Where it is running

• Georgia Regents University — Augusta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.